ENGOT-EN9/LEAP-001: A phase III, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer
dc.contributor.author | Marth, C. | |
dc.contributor.author | Vulsteke, C. | |
dc.contributor.author | Rubio, M. J. | |
dc.contributor.author | Makker, V. | |
dc.contributor.author | Braicu, E. I. | |
dc.contributor.author | McNeish, I. A. | |
dc.contributor.author | Radoslaw, M. | |
dc.contributor.author | Ayhan, A. | |
dc.contributor.author | Hasegawa, K. | |
dc.contributor.author | Wu, X. | |
dc.contributor.author | Dutta, L. | |
dc.contributor.author | Xu, C. | |
dc.contributor.author | Keefe, S. M. | |
dc.contributor.author | Lee, J. | |
dc.contributor.author | Pıgnata, S. | |
dc.date.accessioned | 2020-10-20T07:50:22Z | |
dc.date.available | 2020-10-20T07:50:22Z | |
dc.date.issued | 2019 | |
dc.identifier.issn | 0923-7534 | en_US |
dc.identifier.uri | http://hdl.handle.net/11727/4935 | |
dc.description.sponsorship | European Soc Med Oncol; Japanese Soc Med Oncol | en_US |
dc.language.iso | eng | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | ENGOT-EN9/LEAP-001: A phase III, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer | en_US |
dc.type | conferenceObject | en_US |
dc.relation.journal | ANNALS OF ONCOLOGY | en_US |
dc.identifier.volume | 30 | en_US |
dc.identifier.wos | 000491295503112 | en_US |
Bu öğenin dosyaları:
Dosyalar | Boyut | Biçim | Göster |
---|---|---|---|
Bu öğe ile ilişkili dosya yok. |